[REGN] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -31.68%
YoY- -15.99%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 3,434,300 3,362,700 3,158,100 3,162,100 3,414,400 2,936,200 2,857,200 13.01%
PBT 1,147,600 1,110,800 1,082,900 858,000 1,324,700 1,509,800 963,200 12.35%
Tax -12,000 103,000 114,500 40,200 127,600 194,100 111,100 -
NP 1,159,600 1,007,800 968,400 817,800 1,197,100 1,315,700 852,100 22.73%
Tax Rate 1.05% -9.27% -10.57% -4.69% -9.63% -12.86% -11.53% -
Total Cost 2,274,700 2,354,900 2,189,700 2,344,300 2,217,300 1,620,500 2,005,100 8.74%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 33.77 29.97 30.66 25.86 35.06 44.81 29.82 8.62%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 10.88 9.48 9.05 7.64 11.19 11.66 7.47 28.40%
EPS Diluted 10.19 8.89 8.50 7.17 10.50 11.66 7.47 22.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.